RICHMOND, Va., May 17 (UPI) -- An immunity biomarker may predict a breast cancer patient's risk of cancer recurrence, Virginia researchers say.
Masoud Manjili, assistant professor of microbiology and immunology at Virginia Commonwealth University Massey Cancer Center, and colleagues say the breakthrough may lead to new genetic testing.